Treatment of glioblastoma by photodynamic therapy with the aid of synthesized silver nanoparticles by green chemistry from Citrus aurantium
Abstract
Keywords
References
- [1] Obara-Michlewska M, Szeliga M. Targeting glutamine addiction in gliomas. Cancers. 2020; 12(2): 310.
- [2] Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016. Neuro-oncology. 2019; 21(Supplement_5): v1-v100.
- [3] Cuddapah VA, Robel S, Watkins S, Sontheimer H. A neurocentric perspective on glioma invasion. Nat Rev Neurosci. 2014; 15(7): 455-465.
- [4] Mao H, LeBrun DG, Yang J, Zhu VF, Li M. Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets. Cancer Invest. 2012; 30(1): 48-56.
- [5] Alphandéry E. Nano-therapies for glioblastoma treatment. Cancers. 2020; 12(1): 242.
- [6] Liang P, Shi H, Zhu W, Gui Q, Xu Y, Meng J, et al. Silver nanoparticles enhance the sensitivity of temozolomide on human glioma cells. Oncotarget. 2017; 8(5): 7533.
- [7]Asharani P, Hande MP, Valiyaveettil S. Anti-proliferative activity of silver nanoparticles. BMC Cell Biol. 2009; 10(1): 1-14.
- [8] Greulich C, Diendorf J, Simon T, Eggeler G, Epple M, Köller M. Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. Acta Biomater. 2011; 7(1) :347-354.
Details
Primary Language
English
Subjects
Pharmaceutical Biochemistry
Journal Section
Research Article
Authors
Ömer Erdoğan
*
Türkiye
Mürüvvet Abbak
Türkiye
Gülen Melike Demirbolat
Türkiye
Mehran Aksel
Türkiye
Salih Paşa
Türkiye
Gizem Yalcin
Türkiye
Özge Çevik
Türkiye
Publication Date
June 28, 2025
Submission Date
June 7, 2021
Acceptance Date
August 26, 2021
Published in Issue
Year 2021 Volume: 25 Number: 5